Works matching IS 17588340 AND DT 2019 AND VI 11


Results: 189
    1
    2

    Opportunities for cannabis in supportive care in cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919866362
    By:
    • Kleckner, Amber S.;
    • Kleckner, Ian R.;
    • Kamen, Charles S.;
    • Tejani, Mohamedtaki A.;
    • Janelsins, Michelle C.;
    • Morrow, Gary R.;
    • Peppone, Luke J.
    Publication type:
    Article
    3
    4
    5

    Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919864236
    By:
    • Gullo, Giuseppe;
    • Eustace, Alex J.;
    • Canonici, Alexandra;
    • Collins, Denis M.;
    • Kennedy, Michael J.;
    • Grogan, Liam;
    • Breathhnach, Oscar;
    • McCaffrey, John;
    • Keane, Maccon;
    • Martin, Michael J.;
    • Gupta, Rajnish;
    • Leonard, Gregory;
    • O'Connor, Miriam;
    • Calvert, Paula M.;
    • Donnellan, Paul;
    • Walshe, Janice;
    • McDermott, Enda;
    • Scott, Kathleen;
    • Hernando, Andres;
    • Parker, Imelda
    Publication type:
    Article
    6
    7

    TIMP-3 as a therapeutic target for cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919864247
    By:
    • Su, Chun-Wen;
    • Lin, Chiao-Wen;
    • Yang, Wei-En;
    • Yang, Shun-Fa
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    Molecular targeted therapy of BRAF -mutant colorectal cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919856494
    By:
    • Ducreux, Michel;
    • Chamseddine, Ali;
    • Laurent-Puig, Pierre;
    • Smolenschi, Cristina;
    • Hollebecque, Antoine;
    • Dartigues, Peggy;
    • Samallin, Emmanuelle;
    • Boige, Valérie;
    • Malka, David;
    • Gelli, Maximiliano
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919833864
    By:
    • Palumbo, Raffaella;
    • Sottotetti, Federico;
    • Quaquarini, Erica;
    • Gambaro, Anna;
    • Ferzi, Antonella;
    • Tagliaferri, Barbara;
    • Teragni, Cristina;
    • Licata, Luca;
    • Serra, Francesco;
    • Lapidari, Pietro;
    • Bernardo, Antonio
    Publication type:
    Article
    23
    24
    25
    26
    27

    Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919853971
    By:
    • Crocamo, Susanne;
    • Binato, Renata;
    • de Paula, Bruno;
    • Vignal, Giselle;
    • Magalhães, Lídia;
    • Sarmento, Roberta;
    • Accioly, Maria Theresa;
    • Small, Isabele;
    • Gioia, Sandra;
    • Maroun, Pedro;
    • Moutinho, Pamela;
    • Freitas, Vivianne;
    • Catein, Karuline;
    • Abdelhay, Eliana
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919853971
    By:
    • Crocamo, Susanne;
    • Binato, Renata;
    • de Paula, Bruno;
    • Vignal, Giselle;
    • Magalhães, Lídia;
    • Sarmento, Roberta;
    • Accioly, Maria Theresa;
    • Small, Isabele;
    • Gioia, Sandra;
    • Maroun, Pedro;
    • Moutinho, Pamela;
    • Freitas, Vivianne;
    • Catein, Karuline;
    • Abdelhay, Eliana
    Publication type:
    Article
    43

    Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919839928
    By:
    • Passiglia, Francesco;
    • Galvano, Antonio;
    • Castiglia, Marta;
    • Incorvaia, Lorena;
    • Calò, Valentina;
    • Listì, Angela;
    • Mazzarisi, Salvatore;
    • Perez, Alessandro;
    • Gallina, Giuseppe;
    • Rizzo, Sergio;
    • Soto Parra, Hector;
    • Bazan, Viviana;
    • Russo, Antonio
    Publication type:
    Article
    44
    45

    Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919846421
    By:
    • Bruera, Gemma;
    • Massacese, Silvia;
    • Pepe, Francesco;
    • Malapelle, Umberto;
    • Dal Mas, Antonella;
    • Ciacco, Eugenio;
    • Calvisi, Giuseppe;
    • Troncone, Giancarlo;
    • Simmaco, Maurizio;
    • Ricevuto, Enrico
    Publication type:
    Article
    46
    47
    48

    Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919841233
    By:
    • Le Large, Tessa Ya Sung;
    • El Hassouni, Btissame;
    • Funel, Niccola;
    • Kok, Bart;
    • Piersma, Sander R.;
    • Pham, Thang V.;
    • Olive, Kenneth P.;
    • Kazemier, Geert;
    • van Laarhoven, Hanneke W.M.;
    • Jimenez, Connie R.;
    • Bijlsma, Maarten F.;
    • Giovannetti, Elisa
    Publication type:
    Article
    49

    Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919833867
    By:
    • Bellet, Meritxell;
    • Ahmad, Faten;
    • Villanueva, Rafael;
    • Valdivia, Carolina;
    • Palomino-Doza, Julián;
    • Ruiz, Ada;
    • Gonzàlez, Xavier;
    • Adrover, Encarna;
    • Azaro, Analía;
    • Valls-Margarit, Maria;
    • Parra, Josep Lluís;
    • Aguilar, Juan;
    • Vidal, Maria;
    • Martín, Anastasi;
    • Gavilá, Joaquín;
    • Escrivá-de-Romaní, Santiago;
    • Perelló, Antonia;
    • Hernando, Cristina;
    • Lahuerta, Ainhara;
    • Zamora, Pilar
    Publication type:
    Article
    50